Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

BACKGROUND: Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend routine prophylactic coverage with granulocyte colony-stimulating factor (G-CSF)—such as pegfilgrastim—for most patients receiving chemotherapy with an intermediate...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Weycker, Derek, Doroff, Robin, Hanau, Ahuva, Bowers, Charles, Belani, Rajesh, Chandler, David, Lonshteyn, Alexander, Bensink, Mark, Lyman, Gary H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688232/
https://ncbi.nlm.nih.gov/pubmed/31399079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6010-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi